Archer Aviation Inc vs Recursion Pharmaceuticals Inc — how do they compare? Archer Aviation Inc trades at $6.45 (market cap $5.23B), while Recursion Pharmaceuticals Inc trades at $3.33 (market cap $1.81B). The key difference: Archer Aviation Inc is far larger — about 2.9× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| ACHR | RXRX | |
|---|---|---|
Market Cap | $5.23B | $1.81B |
Sector | Industrials | Health |
52-Week High | $13.64 | $6.79 |
52-Week Low | $4.44 | $2.84 |
Enterprise Value | $3.79B | $1.33B |
Trailing returns across standard periods
Latest headlines on both assets
Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.
Read more on ACHR →Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →